ARCHIVES

MOPP Consequences, Including Increase In cure Rate, Describe By DeVita

This article is from The Cancer Letter archive.

Vol. 05 No. 21 | May 25, 1979

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

April 22, 1988

Talbot, Schein Ask Weickar for 41.3 Billion for NCI

May 6, 1983

NCI Advisory Group, Other Cancer Meeting

May 26, 1978

Hopkins to Commit Own Money for Junior Faculty Research

May 2, 1986

Editorial: A Record-Breaking Year for The Cancer Letter

December 19, 2014

PhRMA’s New Ethics Code Prohibits Trinkets, Dinners; Speaking Fees Still OK.

July 11, 2008